These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease. Hashimoto D; Asakura S; Matsuoka K; Sakoda Y; Koyama M; Aoyama K; Tanimoto M; Teshima T Eur J Immunol; 2007 Jan; 37(1):271-81. PubMed ID: 17154260 [TBL] [Abstract][Full Text] [Related]
13. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment. Drobyski WR; Majewski D; Ozker K; Hanson G J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263 [TBL] [Abstract][Full Text] [Related]
14. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines. Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135 [TBL] [Abstract][Full Text] [Related]
15. Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes. Margalit M; Ilan Y; Ohana M; Safadi R; Alper R; Sherman Y; Doviner V; Rabbani E; Engelhardt D; Nagler A Bone Marrow Transplant; 2005 Jan; 35(2):191-7. PubMed ID: 15558045 [TBL] [Abstract][Full Text] [Related]
16. Graft-versus-host disease: liver morphology and pheno/genotypes of inflammatory cells and target cells in sex-mismatched allogeneic bone marrow transplant patients. Andersen CB; Horn T; Sehested M; Junge J; Jacobsen N Transplant Proc; 1993 Feb; 25(1 Pt 2):1250-4. PubMed ID: 8442105 [No Abstract] [Full Text] [Related]
17. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers. Schilbach K; Schick J; Wehrmann M; Wollny G; Simon P; Schlegel PG; Eyrich M Transplantation; 2007 Jul; 84(2):214-22. PubMed ID: 17667813 [TBL] [Abstract][Full Text] [Related]
18. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation. Li JM; Waller EK Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532 [TBL] [Abstract][Full Text] [Related]